Expanded Indications for Neoadjuvant Endocrine Therapy in Early-Stage Breast Cancer During the COVID-19 Pandemic.

Despite these limitations, our results demonstrate a clear trend of neoadjuvant treatment expansion during the first year of the pandemic.

also in 19,460 other papers

The findings showed a highly significant association between post-treatment Ki-67 and recurrence-free survival.

also in 132,142 other papers